$GKOS
GLAUKOS Corp

2022 Q3 Form 10-Q Financial Statement

#000155837022012314 Filed on August 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $71.27M $72.69M $73.24M
YoY Change -4.61% -6.93% 0.01%
Cost Of Revenue $16.86M $17.83M $16.87M
YoY Change 9.7% 0.42% -13.91%
Gross Profit $54.41M $54.85M $56.38M
YoY Change -8.31% -9.09% 5.09%
Gross Profit Margin 76.34% 75.47% 76.97%
Selling, General & Admin $47.15M $49.90M $47.57M
YoY Change 6.02% 10.15% 8.62%
% of Gross Profit 86.66% 90.97% 84.37%
Research & Development $28.87M $31.71M $26.68M
YoY Change 0.08% 30.74% 25.58%
% of Gross Profit 53.06% 57.81% 47.32%
Depreciation & Amortization $7.894M $7.890M $26.19M
YoY Change 6.82% 6.78% 253.86%
% of Gross Profit 14.51% 14.38% 46.45%
Operating Expenses $76.02M $91.61M $74.24M
YoY Change 57.34% 22.88% 14.16%
Operating Profit -$21.61M -$36.76M -$17.87M
YoY Change -296.04% 158.47% 56.86%
Interest Expense $3.481M $3.414M -$3.152M
YoY Change -211.5% 3.27% -38.56%
% of Operating Profit
Other Income/Expense, Net -$5.718M -$8.881M -$4.366M
YoY Change 24.52% 190.99% 74.71%
Pretax Income -$27.33M -$45.64M -$22.24M
YoY Change -524.89% 164.22% 60.08%
Income Tax $200.0K -$100.0K -$363.0K
% Of Pretax Income
Net Earnings -$27.58M -$45.54M -$21.87M
YoY Change -542.63% 160.47% 105.41%
Net Earnings / Revenue -38.69% -62.65% -29.86%
Basic Earnings Per Share -$0.58 -$0.96 -$0.47
Diluted Earnings Per Share -$0.58 -$0.96 -$0.47
COMMON SHARES
Basic Shares Outstanding 47.60M 47.36M 46.89M
Diluted Shares Outstanding 47.61M 47.36M

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $361.6M $391.2M $414.1M
YoY Change -15.7% -6.54% 2.39%
Cash & Equivalents $104.0M $102.6M $100.7M
Short-Term Investments $257.6M $288.6M $313.3M
Other Short-Term Assets $18.28M $16.03M $15.63M
YoY Change 2.17% -5.16% 18.38%
Inventory $34.18M $27.84M $23.01M
Prepaid Expenses
Receivables $34.77M $36.03M $33.44M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $448.8M $471.1M $486.1M
YoY Change -10.56% -3.96% 3.55%
LONG-TERM ASSETS
Property, Plant & Equipment $87.31M $80.92M $68.97M
YoY Change 43.6% 48.81% 187.28%
Goodwill $66.13M $66.13M $66.13M
YoY Change 0.0% 0.0% 0.0%
Intangibles $314.1M $320.3M $332.8M
YoY Change -7.35% -7.22% -6.96%
Long-Term Investments
YoY Change
Other Assets $18.83M $18.54M $18.52M
YoY Change 4.53% 5.0% 10.26%
Total Long-Term Assets $559.6M $560.2M $563.6M
YoY Change -0.48% 1.26% 5.13%
TOTAL ASSETS
Total Short-Term Assets $448.8M $471.1M $486.1M
Total Long-Term Assets $559.6M $560.2M $563.6M
Total Assets $1.008B $1.031B $1.050B
YoY Change -5.23% -1.19% 4.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.47M $21.29M $7.333M
YoY Change 35.54% 206.08% 67.76%
Accrued Expenses $49.15M $48.21M $56.03M
YoY Change -10.62% -23.69% 23.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $60.62M $69.51M $63.36M
YoY Change -4.47% -80.11% 27.48%
LONG-TERM LIABILITIES
Long-Term Debt $353.4M $353.2M $352.7M
YoY Change 0.25% 384.43% 41.03%
Other Long-Term Liabilities $9.494M $9.448M $9.494M
YoY Change 5.71% 10.1% 35.07%
Total Long-Term Liabilities $9.494M $9.448M $9.494M
YoY Change 5.71% 10.1% 35.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.62M $69.51M $63.36M
Total Long-Term Liabilities $9.494M $9.448M $9.494M
Total Liabilities $459.9M $468.8M $462.5M
YoY Change -0.68% 2.05% 36.83%
SHAREHOLDERS EQUITY
Retained Earnings -$432.9M -$405.4M -$365.2M
YoY Change 26.1% 15.96% 17.79%
Common Stock $985.5M $971.7M $952.5M
YoY Change 4.44% 4.11% -2.47%
Preferred Stock
YoY Change
Treasury Stock (at cost) $132.0K $132.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares $28.00K $28.00K
Shareholders Equity $548.6M $562.5M $587.2M
YoY Change
Total Liabilities & Shareholders Equity $1.008B $1.031B $1.050B
YoY Change -5.23% -1.19% 4.4%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$27.58M -$45.54M -$21.87M
YoY Change -542.63% 160.47% 105.41%
Depreciation, Depletion And Amortization $7.894M $7.890M $26.19M
YoY Change 6.82% 6.78% 253.86%
Cash From Operating Activities -$26.52M -$12.21M -$4.651M
YoY Change -249.04% -265.19% -143.88%
INVESTING ACTIVITIES
Capital Expenditures -$6.039M -$9.401M -$9.327M
YoY Change -39.1% -17.26% 333.81%
Acquisitions
YoY Change
Other Investing Activities $30.43M $19.03M $455.0K
YoY Change -288.46% 104.09% -134.47%
Cash From Investing Activities $24.39M $9.630M -$8.872M
YoY Change -193.58% -572.75% 156.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.206M 106.0K 1.617M
YoY Change 8.77% -99.35% -81.33%
NET CHANGE
Cash From Operating Activities -26.52M -12.21M -4.651M
Cash From Investing Activities 24.39M 9.630M -8.872M
Cash From Financing Activities 4.206M 106.0K 1.617M
Net Change In Cash 2.082M -2.470M -11.91M
YoY Change -147.25% -111.37% -175.35%
FREE CASH FLOW
Cash From Operating Activities -$26.52M -$12.21M -$4.651M
Capital Expenditures -$6.039M -$9.401M -$9.327M
Free Cash Flow -$20.48M -$2.805M $4.676M
YoY Change -173.9% -114.96% -63.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47356000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46306000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47205000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46011000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Registrant Name
EntityRegistrantName
GLAUKOS Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001192448
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Trading Symbol
TradingSymbol
GKOS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37463
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0945406
dei Entity Address Address Line1
EntityAddressAddressLine1
One Glaukos Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Aliso Viejo
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92656
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
367-9600
dei Security12b Title
Security12bTitle
Common Stock
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47596861
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102553000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100708000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
288637000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
313343000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36032000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33438000
CY2022Q2 us-gaap Inventory Net
InventoryNet
27842000
CY2021Q4 us-gaap Inventory Net
InventoryNet
23011000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16033000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15626000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
471097000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
486126000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9128000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9416000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80921000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68969000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26451000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28142000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
47812000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
49022000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
320325000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
332781000
CY2022Q2 us-gaap Goodwill
Goodwill
66134000
CY2021Q4 us-gaap Goodwill
Goodwill
66134000
CY2022Q2 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
9410000
CY2021Q4 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
9108000
CY2022Q2 us-gaap Assets
Assets
1031278000
CY2021Q4 us-gaap Assets
Assets
1049698000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
21294000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7333000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56027000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
69508000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48214000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Liabilities
Liabilities
468801000
CY2021Q4 us-gaap Liabilities
Liabilities
462547000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63360000
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
280713000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
280026000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29361000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29650000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
72464000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
72699000
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7307000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7318000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9448000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9494000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47448000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46993000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47420000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46965000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
48000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
47000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
971646000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
952432000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3715000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-405370000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-365211000
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
562477000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
587151000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1031278000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1049698000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72685000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78093000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140366000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
146061000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17833000
us-gaap Gross Profit
GrossProfit
111669000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17759000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34896000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34392000
CY2022Q2 us-gaap Gross Profit
GrossProfit
54852000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49900000
CY2021Q2 us-gaap Gross Profit
GrossProfit
60334000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3730000
us-gaap Gross Profit
GrossProfit
105470000
CY2022Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10000000
CY2021Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
5000000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-362000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10000000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
5000000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
30000000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45300000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93849000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87221000
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
31712000
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
24256000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
58589000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
45475000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
91612000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
74556000
us-gaap Operating Expenses
OperatingExpenses
132438000
us-gaap Operating Expenses
OperatingExpenses
137696000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-36760000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14222000
us-gaap Operating Income Loss
OperatingIncomeLoss
-26968000
us-gaap Operating Income Loss
OperatingIncomeLoss
-26027000
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
384000
CY2021Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
342000
us-gaap Interest And Other Income
InterestAndOtherIncome
671000
us-gaap Interest And Other Income
InterestAndOtherIncome
725000
CY2022Q2 us-gaap Interest Expense
InterestExpense
3414000
CY2021Q2 us-gaap Interest Expense
InterestExpense
3306000
us-gaap Interest Expense
InterestExpense
6830000
us-gaap Interest Expense
InterestExpense
6535000
CY2022Q2 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-5851000
CY2021Q2 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-88000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-6811000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-1627000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8881000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3052000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12970000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7437000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45641000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17274000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39938000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33464000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-105000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
208000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
221000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
487000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-45536000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17482000
us-gaap Net Income Loss
NetIncomeLoss
-40159000
us-gaap Net Income Loss
NetIncomeLoss
-33951000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-352000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
238000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47205000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10539000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-328000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1158000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
179000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46011000
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-994000
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-114000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47356000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46306000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6923000
us-gaap Net Income Loss
NetIncomeLoss
-33951000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
666000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3402000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
5377000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-45536000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17482000
us-gaap Net Income Loss
NetIncomeLoss
-40159000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
597564000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-476000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4888000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-531000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-328000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45864000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17958000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43889000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34303000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
587151000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1515000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-45536000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
562477000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
667449000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
17035000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8748000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
124000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-16469000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589774000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4525000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7984000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-476000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-17482000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
584325000
us-gaap Profit Loss
ProfitLoss
-40159000
us-gaap Profit Loss
ProfitLoss
-33951000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3044000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2313000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12456000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12456000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2296000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2287000
gkos Amortization Of Financing Cost
AmortizationOfFinancingCost
687000
gkos Amortization Of Financing Cost
AmortizationOfFinancingCost
687000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-12000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-48000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
35000
us-gaap Share Based Compensation
ShareBasedCompensation
17462000
us-gaap Share Based Compensation
ShareBasedCompensation
16732000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2269000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-827000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1679000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
442000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
516000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
96000
gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
-45000
gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
1551000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5151000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1863000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3296000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
5665000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-602000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-3758000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8367000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15324000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
155000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-175000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2432000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11569000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
36938000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
97233000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
56748000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
103692000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16005000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28542000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3733000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23297000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1921000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
22824000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1785000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1549000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1954000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2812000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
236000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
453000
gkos Proceeds From Tenant Allowance
ProceedsFromTenantAllowance
12668000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1516000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33776000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1260000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-498000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1557000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21550000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110124000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106162000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111681000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127712000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
240000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
220000
us-gaap Interest Paid Net
InterestPaidNet
2191000
us-gaap Interest Paid Net
InterestPaidNet
1890000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3310000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4618000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions. Management considers many factors in selecting appropriate financial accounting policies and controls and in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, this process may result in actual results differing materially from those estimated amounts used in the preparation of the condensed consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s condensed consolidated financial statements as of and for the three and six months ended June 30, 2022 reflect the Company’s estimates of the impact of the ongoing COVID-19 pandemic. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company’s business, results of operations and financial condition, including sales, expenses, reserves and allowances, manufacturing, clinical trials, research and development costs and employee-related amounts, will depend on future developments that are uncertain, including the duration and severity of the COVID-19 outbreak, the severity and transmission rates of new and more contagious and/or vaccine-resistant variants of COVID-19, and the actions taken to contain it or treat COVID-19, including the availability, distribution, rate of public acceptance and efficacy of vaccines for COVID-19, as well as the economic impact on local, regional, national and international customers and markets. As a result, there may be changes to the Company’s estimates regarding the impact of COVID-19 in future periods.</p>
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102553000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100708000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
9128000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
9416000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111681000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110124000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
288637000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
7010000
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
10084000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
314355000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
90000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9506000
CY2022Q2 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
294103000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5477000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1102000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
313343000
CY2022Q2 gkos Available For Sale Securities Continuous Unrealized Loss Position Accumulated Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLosses
5500000
CY2021Q4 gkos Available For Sale Securities Continuous Unrealized Loss Position Accumulated Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLosses
1000000.0
CY2022Q2 gkos Available For Sale Securities Allowance For Credit Losses
AvailableForSaleSecuritiesAllowanceForCreditLosses
0
CY2021Q4 gkos Available For Sale Securities Allowance For Credit Losses
AvailableForSaleSecuritiesAllowanceForCreditLosses
0
CY2022Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
37188000
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
34805000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1156000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1367000
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
36032000
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
33438000
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12840000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6495000
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4918000
CY2022Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4631000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
33759000
CY2021Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4196000
CY2022Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
3959000
CY2022Q2 us-gaap Inventory Gross
InventoryGross
27842000
CY2022Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
101880000
CY2021Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2419000
CY2021Q4 us-gaap Inventory Gross
InventoryGross
23011000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
51177000
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
3698000
CY2022Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
131064000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21893000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1693000
CY2022Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
58600000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
29284000
CY2022Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
9481000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
17015000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
26445000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30704000
CY2022Q2 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
48214000
CY2021Q4 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
56027000
CY2022Q2 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2021Q4 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
546000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3417000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
7495000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3334000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
5184000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3292000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
5340000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3362000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
5500000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3467000
CY2022Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
72464000
CY2022Q2 gkos Lessee Operating Lease Option To Extend Value
LesseeOperatingLeaseOptionToExtendValue
20600000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2022Q2 gkos Lessee Financing Lease Option To Extend Value
LesseeFinancingLeaseOptionToExtendValue
75800000
us-gaap Lessee Operating Lease Lease Not Yet Commenced Existence Of Option To Extend
LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfOptionToExtend
true
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
64875000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
201425000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
52419000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
213881000
CY2022Q2 us-gaap Goodwill
Goodwill
66134000
CY2022Q2 us-gaap Goodwill
Goodwill
66134000
CY2021Q4 us-gaap Goodwill
Goodwill
66134000
CY2021Q4 us-gaap Goodwill
Goodwill
66134000
CY2022Q2 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
64875000
CY2022Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
386459000
CY2021Q4 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
52419000
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
398915000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
12456000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
24912000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24619000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
22092000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
22092000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
95254000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
201425000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72685000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78093000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140366000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
146061000
gkos Period For Payment On Invoice Terms
PeriodForPaymentOnInvoiceTerms
P30D
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8812000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9203000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8545000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9293000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10539000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7984000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17462000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16732000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
75900000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0023
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0055
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
26900000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
25800000
CY2022Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
8800000
CY2022Q2 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2021Q4 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2022Q2 gkos Number Of Months Of Lease Term For Adjustments Of Letters Of Credit Balance Outstanding To Begin
NumberOfMonthsOfLeaseTermForAdjustmentsOfLettersOfCreditBalanceOutstandingToBegin
37
CY2018Q4 gkos Frequency Of Adjustments Of Letters Of Credit Balance Outstanding
FrequencyOfAdjustmentsOfLettersOfCreditBalanceOutstanding
P12M
gkos Adjustment Percentage Of Letters Of Credit Balance Outstanding
AdjustmentPercentageOfLettersOfCreditBalanceOutstanding
0.20
CY2022Q2 gkos Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments
MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments
2000000.0
CY2022Q2 gkos Number Of Other Irrevocable Letters Of Credit Outstanding
NumberOfOtherIrrevocableLettersOfCreditOutstanding
1
CY2022Q2 gkos Restricted Cash Pledged For Office Lease Agreement
RestrictedCashPledgedForOfficeLeaseAgreement
300000
CY2022Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
7500000
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
7300000
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
7300000
CY2022Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
7600000
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
7400000
gkos Number Of Business Activities
NumberOfBusinessActivities
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001558370-22-012314-index-headers.html Edgar Link pending
0001558370-22-012314-index.html Edgar Link pending
0001558370-22-012314.txt Edgar Link pending
0001558370-22-012314-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gkos-20220630.xsd Edgar Link pending
gkos-20220630x10q.htm Edgar Link pending
gkos-20220630x10q_htm.xml Edgar Link completed
gkos-20220630xex31d1.htm Edgar Link pending
gkos-20220630xex31d2.htm Edgar Link pending
gkos-20220630xex32d1.htm Edgar Link pending
gkos-20220630xex32d2.htm Edgar Link pending
gkos-20220630_cal.xml Edgar Link unprocessable
gkos-20220630_def.xml Edgar Link unprocessable
gkos-20220630_lab.xml Edgar Link unprocessable
gkos-20220630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending